Cargando…

Reporting renal biopsies from Cyprus: a systematic approach

BACKGROUND: The etiology of renal disease varies in different parts of the world. In the Middle East, half of all patients reaching end-stage are categorised as either unknown etiology or hypertension-related nephropathy. OBJECTIVES: To report a renal biopsy series, in a reproducible format and mann...

Descripción completa

Detalles Bibliográficos
Autores principales: Oygar, Düriye Deren, Neild, Guy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Diabetic Nephropathy Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607988/
https://www.ncbi.nlm.nih.gov/pubmed/28975106
http://dx.doi.org/10.15171/jnp.2017.38
_version_ 1783265370313850880
author Oygar, Düriye Deren
Neild, Guy H.
author_facet Oygar, Düriye Deren
Neild, Guy H.
author_sort Oygar, Düriye Deren
collection PubMed
description BACKGROUND: The etiology of renal disease varies in different parts of the world. In the Middle East, half of all patients reaching end-stage are categorised as either unknown etiology or hypertension-related nephropathy. OBJECTIVES: To report a renal biopsy series, in a reproducible format and manner, so that data can be compared directly among other series. PATIENTS AND METHODS: Biopsies of native kidneys were performed in a 10-year period, at a tertiary referral hospital that provides the entire nephrology service for north Cyprus. Data are reported from 153 patients older than 17 years, who were either Turkish-Cypriot or from the Turkish mainland. RESULTS: Mean biopsy rate was 48 per million population (pmp) per year. Mean age was 45.7 years (range 18-78). Overall, the sex distribution was similar (male 51%). The most common histopathological categories were primary glomerulonephritis (GN) (56%), secondary GN (27%), and tubulo-interstitial disease (14%). Of those with primary GN, 29% had secondary (2o) focal and segmental glomerulosclerosis (FSGS) (29%), followed by IgA nephropathy (24 %), membranous 18% and a further 11 patients with 1o FSGS (12%). The incidence of IgA nephropathy was 6.3 per pmp/year. When expressed as a percentage of the annual biopsy rate, 14% of all biopsies showed IgA nephropathy. CONCLUSIONS: To compare data among centres, they must be expressed in terms of the population (incidence pmp/year) and the biopsy rate. In our population, secondary FSGS is common and uncharacterised and we believe many will be caused by monogenic disease.
format Online
Article
Text
id pubmed-5607988
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Society of Diabetic Nephropathy Prevention
record_format MEDLINE/PubMed
spelling pubmed-56079882017-10-03 Reporting renal biopsies from Cyprus: a systematic approach Oygar, Düriye Deren Neild, Guy H. J Nephropathol Original Article BACKGROUND: The etiology of renal disease varies in different parts of the world. In the Middle East, half of all patients reaching end-stage are categorised as either unknown etiology or hypertension-related nephropathy. OBJECTIVES: To report a renal biopsy series, in a reproducible format and manner, so that data can be compared directly among other series. PATIENTS AND METHODS: Biopsies of native kidneys were performed in a 10-year period, at a tertiary referral hospital that provides the entire nephrology service for north Cyprus. Data are reported from 153 patients older than 17 years, who were either Turkish-Cypriot or from the Turkish mainland. RESULTS: Mean biopsy rate was 48 per million population (pmp) per year. Mean age was 45.7 years (range 18-78). Overall, the sex distribution was similar (male 51%). The most common histopathological categories were primary glomerulonephritis (GN) (56%), secondary GN (27%), and tubulo-interstitial disease (14%). Of those with primary GN, 29% had secondary (2o) focal and segmental glomerulosclerosis (FSGS) (29%), followed by IgA nephropathy (24 %), membranous 18% and a further 11 patients with 1o FSGS (12%). The incidence of IgA nephropathy was 6.3 per pmp/year. When expressed as a percentage of the annual biopsy rate, 14% of all biopsies showed IgA nephropathy. CONCLUSIONS: To compare data among centres, they must be expressed in terms of the population (incidence pmp/year) and the biopsy rate. In our population, secondary FSGS is common and uncharacterised and we believe many will be caused by monogenic disease. Society of Diabetic Nephropathy Prevention 2017-07 2017-04-13 /pmc/articles/PMC5607988/ /pubmed/28975106 http://dx.doi.org/10.15171/jnp.2017.38 Text en © 2017 The Author(s) Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Oygar, Düriye Deren
Neild, Guy H.
Reporting renal biopsies from Cyprus: a systematic approach
title Reporting renal biopsies from Cyprus: a systematic approach
title_full Reporting renal biopsies from Cyprus: a systematic approach
title_fullStr Reporting renal biopsies from Cyprus: a systematic approach
title_full_unstemmed Reporting renal biopsies from Cyprus: a systematic approach
title_short Reporting renal biopsies from Cyprus: a systematic approach
title_sort reporting renal biopsies from cyprus: a systematic approach
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607988/
https://www.ncbi.nlm.nih.gov/pubmed/28975106
http://dx.doi.org/10.15171/jnp.2017.38
work_keys_str_mv AT oygarduriyederen reportingrenalbiopsiesfromcyprusasystematicapproach
AT neildguyh reportingrenalbiopsiesfromcyprusasystematicapproach